Annual Operating Expenses
$9.45 M
+$399.00 K+4.41%
March 31, 2024
Summary
- As of February 7, 2025, SNOA annual total operating expenses is $9.45 million, with the most recent change of +$399.00 thousand (+4.41%) on March 31, 2024.
- During the last 3 years, SNOA annual operating expenses has fallen by -$562.00 thousand (-5.62%).
- SNOA annual operating expenses is now -59.82% below its all-time high of $23.51 million, reached on March 31, 2008.
Performance
SNOA Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$2.30 M
+$90.00 K+4.07%
December 31, 2024
Summary
- As of February 7, 2025, SNOA quarterly total operating expenses is $2.30 million, with the most recent change of +$90.00 thousand (+4.07%) on December 31, 2024.
- Over the past year, SNOA quarterly operating expenses has dropped by -$3000.00 (-0.13%).
- SNOA quarterly operating expenses is now -68.96% below its all-time high of $7.41 million, reached on September 30, 2008.
Performance
SNOA Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
SNOA Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.4% | -0.1% |
| 3 y3 years | -5.6% | +14.4% |
| 5 y5 years | -53.1% | +14.4% |
SNOA Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.6% | +4.4% | -27.1% | +14.4% |
| 5 y | 5-year | -53.1% | +4.4% | -52.8% | +14.4% |
| alltime | all time | -59.8% | +609.2% | -69.0% | +150.5% |
Sonoma Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $2.30 M(+4.1%) |
| Sep 2024 | - | $2.21 M(-10.8%) |
| Jun 2024 | - | $2.48 M(-0.8%) |
| Mar 2024 | $9.45 M(+4.4%) | $2.50 M(+8.5%) |
| Dec 2023 | - | $2.30 M(+4.8%) |
| Sep 2023 | - | $2.20 M(-10.1%) |
| Jun 2023 | - | $2.44 M(+21.5%) |
| Mar 2023 | $9.05 M(-8.4%) | $2.01 M(-24.5%) |
| Dec 2022 | - | $2.67 M(+17.6%) |
| Sep 2022 | - | $2.27 M(-9.4%) |
| Jun 2022 | - | $2.50 M(-20.8%) |
| Mar 2022 | $9.88 M(-1.3%) | $3.16 M(+46.0%) |
| Dec 2021 | - | $2.16 M(-2.0%) |
| Sep 2021 | - | $2.21 M(-6.4%) |
| Jun 2021 | - | $2.36 M(-10.0%) |
| Mar 2021 | $10.01 M(-35.5%) | $2.62 M(+22.8%) |
| Dec 2020 | - | $2.13 M(-8.6%) |
| Sep 2020 | - | $2.33 M(-20.1%) |
| Jun 2020 | - | $2.92 M(-40.1%) |
| Mar 2020 | $15.51 M(-23.0%) | $4.88 M(+56.9%) |
| Dec 2019 | - | $3.11 M(-10.2%) |
| Sep 2019 | - | $3.46 M(-14.8%) |
| Jun 2019 | - | $4.06 M(-11.2%) |
| Mar 2019 | $20.14 M(-6.3%) | $4.58 M(-11.9%) |
| Dec 2018 | - | $5.20 M(+2.3%) |
| Sep 2018 | - | $5.08 M(-3.9%) |
| Jun 2018 | - | $5.28 M(-13.1%) |
| Mar 2018 | $21.50 M(+15.3%) | $6.08 M(+9.2%) |
| Dec 2017 | - | $5.57 M(+18.3%) |
| Sep 2017 | - | $4.71 M(-8.6%) |
| Jun 2017 | - | $5.14 M(+5.9%) |
| Mar 2017 | $18.64 M(+7.4%) | $4.86 M(-7.8%) |
| Dec 2016 | - | $5.27 M(+31.1%) |
| Sep 2016 | - | $4.02 M(-10.4%) |
| Jun 2016 | - | $4.49 M(-2.1%) |
| Mar 2016 | $17.36 M(+24.5%) | $4.59 M(-1.2%) |
| Dec 2015 | - | $4.64 M(+17.6%) |
| Sep 2015 | - | $3.95 M(-5.6%) |
| Jun 2015 | - | $4.18 M(+14.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | $13.95 M(-3.5%) | $3.65 M(+1.1%) |
| Dec 2014 | - | $3.60 M(+10.0%) |
| Sep 2014 | - | $3.28 M(-4.2%) |
| Jun 2014 | - | $3.42 M(-2.0%) |
| Mar 2014 | $14.45 M(+2.3%) | $3.49 M(-4.5%) |
| Dec 2013 | - | $3.65 M(-8.1%) |
| Sep 2013 | - | $3.98 M(+19.5%) |
| Jun 2013 | - | $3.33 M(-6.8%) |
| Mar 2013 | $14.12 M(-7.0%) | $3.57 M(+13.3%) |
| Dec 2012 | - | $3.15 M(-21.6%) |
| Sep 2012 | - | $4.02 M(+18.9%) |
| Jun 2012 | - | $3.38 M(-6.1%) |
| Mar 2012 | $15.18 M(+11.2%) | $3.60 M(-14.4%) |
| Dec 2011 | - | $4.21 M(+23.4%) |
| Sep 2011 | - | $3.41 M(-14.1%) |
| Jun 2011 | - | $3.97 M(+19.6%) |
| Mar 2011 | $13.65 M(+14.7%) | $3.32 M(+2.8%) |
| Dec 2010 | - | $3.23 M(-2.7%) |
| Sep 2010 | - | $3.32 M(-12.3%) |
| Jun 2010 | - | $3.79 M(+39.0%) |
| Mar 2010 | $11.89 M(-40.9%) | $2.72 M(+1.0%) |
| Dec 2009 | - | $2.70 M(-12.1%) |
| Sep 2009 | - | $3.07 M(-9.9%) |
| Jun 2009 | - | $3.41 M(+14.4%) |
| Mar 2009 | $20.11 M(-14.5%) | $2.98 M(-22.7%) |
| Dec 2008 | - | $3.85 M(-48.0%) |
| Sep 2008 | - | $7.41 M(+31.2%) |
| Jun 2008 | - | $5.65 M(-5.8%) |
| Mar 2008 | $23.51 M(+11.8%) | $6.00 M(+2.0%) |
| Dec 2007 | - | $5.88 M(-1.5%) |
| Sep 2007 | - | $5.97 M(+5.3%) |
| Jun 2007 | - | $5.67 M(-8.0%) |
| Mar 2007 | $21.03 M(+13.5%) | $6.16 M(+13.8%) |
| Dec 2006 | - | $5.41 M(-218.7%) |
| Sep 2006 | - | -$4.56 M |
| Mar 2006 | $18.53 M(+31.0%) | - |
| Mar 2005 | $14.15 M(+551.9%) | - |
| Mar 2003 | $2.17 M(+62.9%) | - |
| Mar 2002 | $1.33 M | - |
FAQ
- What is Sonoma Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals annual operating expenses year-on-year change?
- What is Sonoma Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals quarterly operating expenses year-on-year change?
What is Sonoma Pharmaceuticals annual total operating expenses?
The current annual operating expenses of SNOA is $9.45 M
What is the all time high annual operating expenses for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high annual total operating expenses is $23.51 M
What is Sonoma Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, SNOA annual total operating expenses has changed by +$399.00 K (+4.41%)
What is Sonoma Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of SNOA is $2.30 M
What is the all time high quarterly operating expenses for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high quarterly total operating expenses is $7.41 M
What is Sonoma Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, SNOA quarterly total operating expenses has changed by -$3000.00 (-0.13%)